Telomir Pharmaceuticals Financials
| TELO Stock | 6.20 0.64 9.36% |
The financial analysis of Telomir Pharmaceuticals is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Telomir Pharmaceuticals includes many different criteria found on its balance sheet. For example, investors should never minimize Telomir Pharmaceuticals' ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Telomir Pharmaceuticals' cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Telomir Pharmaceuticals.
Net Income |
|
With this module, you can analyze Telomir financials for your investing period. You should be able to track the changes in Telomir Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Telomir | Select Account or Indicator |
Understanding current and past Telomir Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Telomir Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Telomir Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in Telomir Pharmaceuticals' official financial statements usually reflect Telomir Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Telomir Pharmaceuticals. For example, before you start analyzing numbers published by Telomir accountants, it's critical to develop an understanding of what Telomir Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Telomir Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Telomir Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Telomir Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Telomir Pharmaceuticals Common. Please utilize our Beneish M Score to check the likelihood of Telomir Pharmaceuticals' management manipulating its earnings.
Telomir Pharmaceuticals Stock Summary
Telomir Pharmaceuticals competes with EnGene Holdings, Exscientia, Exelixis, Eyenovia, and Eyepoint Pharmaceuticals. Telomir Pharmaceuticals is entity of United States. It is traded as Stock on NASDAQ exchange.| Foreign Associate | Canada |
Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 87975F104 |
| Location | Florida; U.S.A |
| Business Address | 855 N Wolfe |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | NYSE Composite |
| Website | telomirpharma.com |
| Phone | (737) 289 0835 |
You should never invest in Telomir Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Telomir Stock, because this is throwing your money away. Analyzing the key information contained in Telomir Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Telomir Pharmaceuticals Key Financial Ratios
Generally speaking, Telomir Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Telomir Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Telomir Pharmaceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Telomir Pharmaceuticals reports annually and quarterly.| Net Income | (13.07 M) | ||||
| Total Asset | 4.77 M | ||||
| Retained Earnings | (14.06 M) |
Telomir Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Telomir Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Telomir Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Telomir Pharmaceuticals competition to find correlations between indicators driving Telomir Pharmaceuticals's intrinsic value. More Info.Telomir Pharmaceuticals Common is rated second in net income category among related companies. It is rated second in total debt category among related companies . Telomir Pharmaceuticals reported last year Net Loss of (11.76 Million). Comparative valuation analysis is a catch-all model that can be used if you cannot value Telomir Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Telomir Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Telomir Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Telomir Pharmaceuticals Systematic Risk
Telomir Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Telomir Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Telomir Pharmaceuticals correlated with the market. If Beta is less than 0 Telomir Pharmaceuticals generally moves in the opposite direction as compared to the market. If Telomir Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Telomir Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Telomir Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Telomir Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
About Telomir Pharmaceuticals Financials
What exactly are Telomir Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Telomir Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Telomir Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Telomir Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Telomir Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Telomir Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Telomir Pharmaceuticals Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Telomir Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Telomir has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Telomir Pharmaceuticals' financials are consistent with your investment objective using the following steps:- Review Telomir Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Telomir Pharmaceuticals' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Telomir Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Telomir Pharmaceuticals' stock is overvalued or undervalued.
Telomir Pharmaceuticals Thematic Clasifications
Telomir Pharmaceuticals Common is part of several thematic ideas from IT to Biotech. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasTelomir Pharmaceuticals May 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Telomir Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Telomir Pharmaceuticals Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Telomir Pharmaceuticals Common based on widely used predictive technical indicators. In general, we focus on analyzing Telomir Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Telomir Pharmaceuticals's daily price indicators and compare them against related drivers.
| Downside Deviation | 12.13 | |||
| Information Ratio | 0.0589 | |||
| Maximum Drawdown | 102.03 | |||
| Value At Risk | (18.79) | |||
| Potential Upside | 23.19 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals Common. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Telomir Stock analysis
When running Telomir Pharmaceuticals' price analysis, check to measure Telomir Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telomir Pharmaceuticals is operating at the current time. Most of Telomir Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telomir Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telomir Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telomir Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is Telomir Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Telomir Pharmaceuticals is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals' market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.